PIMA514582

DOG-1 Recombinant Rabbit Monoclonal Antibody (SP31), Invitrogen™

Manufacturer: Thermo Scientific

Select a Size

Pack Size SKU Availability Price
Each of 1 PIMA514582-Each-of-1 In Stock ₹ 82,147.00

PIMA514582 - Each of 1

₹ 82,147.00

In Stock

Quantity

1

Base Price: ₹ 82,147.00

GST (18%): ₹ 14,786.46

Total Price: ₹ 96,933.46

Antigen

DOG-1

Classification

Recombinant Monoclonal

Concentration

0.057 mg/mL

Formulation

PBS with 1% BSA and 0.1% sodium azide; pH 7.2

Gene Accession No.

Q5XXA6

Gene Symbols

ANO1

Immunogen

Synthetic peptide of human Dog1

Quantity

1 mL

Primary or Secondary

Primary

Target Species

Human

Product Type

Antibody

Isotype

IgG

Applications

Flow Cytometry, Immunocytochemistry, Immunohistochemistry (Paraffin), Western Blot

Clone

SP31

Conjugate

Unconjugated

Gene

ANO1

Gene Alias

ANO1; anoctamin 1; anoctamin 1, calcium activated chloride channel; anoctamin-1; Ca2+-activated Cl- channel; calcium activated chloride channel; discovered on gastrointestinal stromal tumors protein 1; DOG1; FLJ10261; oral cancer overexpressed 2; Oral cancer overexpressed protein 2; ORAOV2; TAOS2; Tmem16a; Transmembrane protein 16A; transmembrane protein 16A (eight membrane-spanning domains); tumor-amplified and overexpressed sequence 2

Host Species

Rabbit

Purification Method

Protein A

Regulatory Status

RUO

Gene ID (Entrez)

55107

Content And Storage

-20° C, Avoid Freeze/Thaw Cycles

Form

Liquid

Related Products

Img

Thermo Scientific

PIMA516358

--

Img

Thermo Scientific

PIMA515710

--

Img

Thermo Scientific

PIMA514821

--

Img

Thermo Scientific

PIMA516368

--

Img

Thermo Scientific

PIMA516421

--

Img

Thermo Scientific

PIMA515795

--

Img

Thermo Scientific

PIMA515501

--

Img

Thermo Scientific

PIMA516409

--

Description

  • MA5-14582 targets Dog1 in IHC (P) applications and shows reactivity with Human samples
  • The MA5-14582 immunogen is synthetic peptide of human Dog1
  • DOG-1, the novel marker, is expressed ubiquitously in gastrointestinal stromal tumors irrespective of kit or PDGFR alpha mutation status.